OncoSec Medical Inc (ONCSQ)

[guti]

This is a very volatile stock that has been on a downtrend for two months(notice it used to be one month or less) and has followed the Keltner channels to a tee. Creating wash and rinse cycles, used for increasing number of shares while lowering the average price, and to make quick profits. It is a normal reaction that happens in all markets with every company, and it is amplified in OTC.

I think that in situations like this, longs should abstain from buying until the floor is shown by a sideways movement that usually stays on for days. This would in turn complicate things for MMs who need to keep the ball rolling and for shorts who would like to cover. But the temptation to buy at such lower prices is too much, since our expectations are high. Such expectations have not change, if anything they’ve increased after ASCO with OncoSec’s plan of a Phase 2b trial, which will focus on a huge milestone “as was discussed at ASCO, our technology is demonstrating an ability to enhance these specific biomarkers and convert anti-PD-1 non-responders into responders. We believe this could be game-changing from a clinical perspective”

This is a growing company and has to be seen for what it is and not for what it might turn out to be years from now. For that reason, I think that hiring a PR at this time will lend itself to the term pump & dump, if something goes wrong. The best PR will be the facts of their findings once the results are out, and they won’t need to pay for such advertisement, but instead they can use the money in better ways. Everyone will be knocking on their door if Dr. Pierce achieves his goals. It is a risky investment, but then again this is not a blue chip company.